Orphanet: Networks
x

Search for a networks

* (*) mandatory field

The KHENERGYZE Study: A Phase IIb Double-blind, Randomised, Placebo-controlled, Multi-centre, Confirmative Three-way Cross-over Study on Cognitive Function With Two Doses of KH176 in Subjects With a Genetically Confirmed Mitochondrial DNA tRNALeu(UUR) m.3243A>G Mutation

  • Type of network : Multinational clinical trials
  • Geographic coverage : European
  • Funding body(ies) : -
  • Sponsor : KHONDRION B.V.
  • Website
  • Coordinator of multinational clinical trial

  • INFORMATION NOT PROVIDED
  • Khondrion B.V.
  • Philips van Leydenlaan 15
  • 6525 NIJMEGEN
  • NETHERLANDS
  • More information
  • Phone  : -
  • Fax  : -
  • Website
Last update: March 2020

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.